Money
SRTD Biotech Secures €31.5 Million for RNA Therapy Development
German biotech startup SRTD raised €31.5 million in a seed round to advance its selectively expressed RNA technology for targeted disease treatment.
November 9, 2026, 02:29 PM·Tech Funding News
